Abbott and WeightWatchers partner to support people living with diabetes in achieving their health goals

Abbott and WeightWatchers partner to support people living with diabetes in achieving their health goals

  • Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health
  • The collaboration will create an integrated, seamless experience between Abbott’s world-leading continuous blood glucose monitoring device1 and WeightWatchers’ number one physician-recommended weight loss program2 to help people better understand and manage their diabetes and weight

ABBOTT PARKSick., August 4, 2022 / PRNewswire / – Abbott (NYSE: ABT) and WW International, Inc. (“WeightWatchers” or “WW”) today announced a strategic partnership that will help people with diabetes better understand and manage their diabetes and weight. Companies are working together to integrate WeightWatchers’ bespoke diabetes weight management program with Abbott’s FreeStyle Libre portfolio® products to create a seamless mobile experience that will provide people with diabetes with the information and insights they need to make healthy changes to their diet, improve glucose levels, and ultimately gain greater control of their health.

Maintaining a healthy body weight and proper nutrition are key to living well with diabetes.3 Still, for many people living with diabetes, determining what to eat and following a meal plan is the most challenging part of managing diabetes.4 Through this partnership, participants can receive glucose insights from Abbott’s FreeStyle Libre sensor technology that show the impact of food choices, along with empirically validated ones.5 WeightWatchers’ Tailored Diabetes Nutrition Guide to Help Them Reach Their Healthier Life Goals.

“We strive to put our customers at the center of everything we do, and this includes forming strategic partnerships with key industry leaders, such as WeightWatchers, to deliver new services and offerings that can dramatically improve the quality of life of those affected. from diabetes, “he said Jared Watkin, senior vice president of Abbott’s diabetes care business. “By combining our world leadership1 FreeStyle Libre glucose monitoring technology with WeightWatchers’ number one doctor recommended weight loss program,2 people with diabetes, particularly those with type 2 diabetes and less intensely managed by doctors, may have the insights they need to take control of their health. “

The two companies will work together to enable Abbott’s FreeStyle Libre continuous glucose monitoring systems and the WeightWatchers mobile app to share information so that people with diabetes can see their glucose data along with WeightWatchers’ tailor-made program. diabetes.

“Lifestyle changes, including changes in eating patterns and activity routines, are shown to be a crucial component of diabetes management and can help improve glycemic control.6” She said Sima Sistani, managing director of WeightWatchers. “We partnered with Abbott, a leader in diabetes care, to enable people with diabetes to reach their weight and healthy lifestyle goals by enjoying the foods they love and managing their glucose levels better.”

The partnership will initially focus on solutions for people living with diabetes on the inside the United States in 2023.

About Abate
Abbott is a global leader in healthcare helping people live more fully at all stages of life. Our portfolio of life-changing technologies spans the healthcare spectrum, with leading businesses and products in the fields of diagnostics, medical devices, nutritional products and branded generic drugs. Our 113,000 colleagues serve people in more than 160 countries.

Connect with Abbott at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

About WW International, Inc.
WeightWatchers is a human-centric tech company powered by the world’s leading commercial weight management program. For nearly six decades, we have inspired millions of people to adopt healthy habits for real life. Through our comprehensive tools, expert coaches and the community, members follow our proven, sustainable and science-based weight loss program. To learn more about WeightWatchers’ approach to healthy living, visit ww.com. For more information on our global business, please visit our corporate website at corporate.ww.com.

Important safety information and guidelines

FreeStyle Libre system 14 days: Failure to use the FreeStyle Libre System for 14 days as indicated on the labeling may result in failure to miss a severe low or high blood glucose event and / or make a treatment decision, resulting in injury. If the readings do not match your symptoms or expectations, use a fingertip reading from a blood glucose meter for treatment decisions. Consult a physician when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.

FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use the FreeStyle Libre 2 or FreeStyle Libre 3 systems as indicated on the labeling may result in the failure of a severe low or high blood glucose event and / or a treatment decision, resulting in injury. If alarms and blood glucose readings do not match symptoms or expectations, use a fingertip reading of a blood glucose meter for treatment decisions. Consult a physician when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.

1Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre wallet versus the number of users for other leading sensor-based blood glucose monitoring systems for personal use.
2 Based on a 2020 IQVIA survey of 14,000 doctors recommending weight loss programs to patients.
3 Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS Jr. Nutritional therapy for adults with diabetes or Prediabetes: a consensus relationship. Diabetes care. 2019 May; 42 (5): 731-754. doi: 10.2337 / dci19-0014. Epub 2019 Apr 18. PMID: 31000505; PMCID: PMC7011201.
4 American Diabetes Association. “5. Facilitating Behavior Change and Well-Being to Improve Health Outcomes: Standards of Medical Care in Diabetes: 2021”. Diabetes treatment 44, no. Supplement 1 (2021): S53-S72.
5 Apolzan JW, LaRose JG, Anton SD, et al. A tailored weight management program for adults with type 2 diabetes: effects on glycemic control. Poster presented at: 82nd Scientific Session of the American Diabetes Association; June 5-6, 2022; New Orleans, LA.
6 American Diabetes Association. Lifestyle Management: Standards of Medical Care in Diabetes — 2019. Diabetes care. 2019; 42 (1): S46 – S60. https://doi.org/10.2337/dc19-S005

SOURCE Abate

Leave a Comment

Your email address will not be published.